Budget 2023Budget 2023


  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now


Lipitor is biggest catalyst to Ranbaxy's growth: Expert

Chirag Talati, pharma analyst at Espirito Santo Securities tells CNBC-TV18 that Ranbaxy is most likely set to go ahead with the launch of the generic version of Lipitor, but how much market share it commands needs to be watched.

first published: Nov 30, 2011 11:55 am


Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows